HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Revlon consent order

This article was originally published in The Rose Sheet

Executive Summary

Federal Trade Commission publishes consent order in the Dec. 29 Federal Register as final step of settlement of alleged violations of unfair practices and unfair methods of competition laws by Revlon's Ultima II ProCollagen Anti-Cellulite Body Complex and PhotoAging Shield products. Under the agreement, Revlon is required to have scientific evidence to support future claims for the effectiveness of cellulite treatments or sunscreen products and to state the SPF value in any ad making sun protection claims. Violation of the order may result in a civil penalty of up to $10,000. FTC gave final approval to the consent agreement with Revlon in November ("The Rose Sheet" Nov. 29, In Brief). FTC filed the complaint in September 1989 ("The Rose Sheet" Sept. 18, 1989, p. 3)

You may also be interested in...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Chart: Weekly Trademark Review -- Nov. 2, 2010

Weekly Trademark Review





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts